EP
About
EIR Pharmaceuticals is a biotechnology company that focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals. Its unique approach uses an intense science-based vetting system and a business-minded, scientific philosophy in pursuing products that are both commercially viable and provide a significant health benefit. The company's team has a strong history in drug discovery, drug development, regulatory affairs, and commercialization, making us well-suited to take products from concept to the marketplace.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 38 investors are based in Dover, Delaware, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Dover, US
Contact Information
linkedin.com/in/••••••••
Find more investors like EIR
Search Investors